- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Inflammasome in Cardiovascular Disease
Authors
Keywords
-
Journal
JACC-Basic to Translational Science
Volume 7, Issue 1, Pages 84-98
Publisher
Elsevier BV
Online
2021-11-04
DOI
10.1016/j.jacbts.2021.08.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Universal Definition and Classification of Heart Failure
- (2021) Biykem Bozkurt et al. JOURNAL OF CARDIAC FAILURE
- AIM2 controls microglial inflammation to prevent experimental autoimmune encephalomyelitis
- (2021) Chunmei Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
- (2021) Eleonora Mezzaroma et al. MOLECULES
- AIM2 in regulatory T cells restrains autoimmune diseases
- (2021) Wei-Chun Chou et al. NATURE
- Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
- (2021) Kaspar Broch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation
- (2021) L. Robert Hollingsworth et al. NATURE
- Structural and biochemical mechanisms of NLRP1 inhibition by DPP9
- (2021) Menghang Huang et al. NATURE
- The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
- (2021) Trevor P. Fidler et al. NATURE
- Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond
- (2021) Peter Libby Cells
- Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction
- (2021) Nathan Mewton et al. CIRCULATION
- VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis
- (2020) Yiyi Li et al. EXPERIMENTAL CELL RESEARCH
- Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function
- (2020) Li Wang et al. NATURE CELL BIOLOGY
- Therapeutic modulation of inflammasome pathways
- (2020) Dhruv Chauhan et al. IMMUNOLOGICAL REVIEWS
- Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease
- (2020) Asad Shabbir et al. Annual Review of Pharmacology and Toxicology
- Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
- (2020) Nadia Bouabdallaoui et al. EUROPEAN HEART JOURNAL
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia
- (2020) Kim S. Robinson et al. SCIENCE
- Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
- (2020) Nathalie Niyonzima et al. EBioMedicine
- Human NLRP1 is a sensor for double-stranded RNA
- (2020) Stefan Bauernfried et al. SCIENCE
- Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca 2+ /Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
- (2019) Takeshi Suetomi et al. CIRCULATION
- Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
- (2019) Thomas S. G. Sehested et al. JAMA Cardiology
- AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model
- (2019) Xuyang Wang et al. LIFE SCIENCES
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- The role of Caspase 1 in ischemia/reperfusion injury of the myocardium.
- (2019) Ali Rauf et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- NLRP3 inflammasome in cardioprotective signaling
- (2019) Coert J Zuurbier JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity
- (2019) Marina Sokolova et al. Frontiers in Immunology
- Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
- (2019) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- Interleukin‐18 in patients with acute coronary syndromes
- (2019) Axel Åkerblom et al. CLINICAL CARDIOLOGY
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated C-Reactive Protein
- (2018) Cory Trankle et al. AMERICAN JOURNAL OF CARDIOLOGY
- The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Wenqiang Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
- (2018) Helison Do Carmo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Double-Strand DNA Sensing Aim2 Inflammasome Regulates Atherosclerotic Plaque Vulnerability
- (2018) Nicole Paulin et al. CIRCULATION
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation
- (2018) Anke Di et al. IMMUNITY
- The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages
- (2018) Charles L. Evavold et al. IMMUNITY
- Evidence that NLRC4 Inflammasome Mediates Apoptotic and Pyroptotic Microglial Death Following Ischemic Stroke
- (2018) Luting Poh et al. BRAIN BEHAVIOR AND IMMUNITY
- IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction
- (2018) Benjamin W. Van Tassell et al. Circulation-Heart Failure
- Interleukin-1β Maturation Triggers Its Relocation to the Plasma Membrane for Gasdermin-D-Dependent and -Independent Secretion
- (2018) Mercedes Monteleone et al. Cell Reports
- Immune mechanisms in heart failure
- (2017) Yingying Zhang et al. EUROPEAN JOURNAL OF HEART FAILURE
- NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
- (2017) Leslie Freeman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
- (2016) Ø. Sandanger et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
- (2016) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Interleukin-1 Blockade in Acute Decompensated Heart Failure
- (2016) Benjamin W. Van Tassell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Pore-forming activity and structural autoinhibition of the gasdermin family
- (2016) Jingjin Ding et al. NATURE
- AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity
- (2016) Antonia Di Micco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cadmium induces NLRP3 inflammasome-dependent pyroptosis in vascular endothelial cells
- (2016) Haiyan Chen et al. TOXICOLOGY LETTERS
- Innate Immune Pattern Recognition: A Cell Biological Perspective
- (2015) Sky W. Brubaker et al. Annual Review of Immunology
- Early Hyperlipidemia Promotes Endothelial Activation via a Caspase-1-Sirtuin 1 PathwaySignificance
- (2015) Ying Yin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome
- (2015) Wenxiu Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- The war against heart failure: the Lancet lecture
- (2015) Eugene Braunwald LANCET
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3
- (2015) Adam Denes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
- (2014) Stefano Toldo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- Cutting Edge: Priming of NK Cells by IL-18
- (2014) J. Chaix et al. JOURNAL OF IMMUNOLOGY
- Inflammasomes and Metabolic Disorders: Old Genes in Modern Diseases
- (2014) Gregory R. Robbins et al. MOLECULAR CELL
- MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
- (2014) X Li et al. Cell Death & Disease
- Sudden Cardiac Death Among Firefighters ≤45 Years of Age in the United States
- (2013) Justin Yang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
- (2013) Benjamin Wallace Van Tassell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
- (2013) Yongliang Wang et al. CARDIOLOGY
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- Interleukin-1β induces a reversible cardiomyopathy in the mouse
- (2013) Benjamin W. Van Tassell et al. INFLAMMATION RESEARCH
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis
- (2013) Maani Hakimi et al. JOURNAL OF VASCULAR SURGERY
- IPAF inflammasome is involved in interleukin-1β production from astrocytes, induced by palmitate; implications for Alzheimer's Disease
- (2013) Li Liu et al. NEUROBIOLOGY OF AGING
- Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
- (2012) Jessica Gage et al. CANADIAN JOURNAL OF CARDIOLOGY
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
- (2012) Benjamin W. Van Tassell et al. PLoS One
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes
- (2010) Marianne Hartford et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- BAY 11-7082, a Nuclear Factor-κB Inhibitor, Reduces Inflammation and Apoptosis in a Rat Cardiac Ischemia-Reperfusion Injury Model
- (2010) Yong Sook Kim et al. International Heart Journal
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria
- (2010) Edward A Miao et al. NATURE IMMUNOLOGY
- AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
- (2009) Veit Hornung et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now